We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Brentuximab Vedotin Associated With Chemotherapy in Untreated Patients With Hodgkin Lymphoma. (BREACH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02292979
Recruitment Status : Completed
First Posted : November 18, 2014
Last Update Posted : August 19, 2022
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
The Lymphoma Academic Research Organisation